FDA recall D-0082-2019

Teva Pharmaceuticals USA · Class II · drug

Product

Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North Whales, PA 19454. NDC 0555-0098-96

Reason for recall

Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.

Distribution

Product was distributed throughout the United States to various distributors who may have further distributed the product.

Key facts

Status
Terminated
Initiation date
2018-09-20
Report date
2018-10-24
Termination date
2019-11-07
Voluntary/Mandated
Voluntary: Firm initiated
Location
North Wales, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0082-2019